new glp-1 drug Eli Lilly to seek approval of weight-loss this year New Guidelines on GLP-1 Drugs
Description
Obesity and cancer
Plaintiffs in these lawsuits allege that some patients developed life-altering complications including gastroparesis, bowel obstruction, cyclic vomiting syndrome, gallbladder disease, pulmonary aspiration during surgery, and sudden vision loss associated with non-arteritic anterior ischemic optic neuropathy (NAION)
J., A Review of Gliptins in 2011, Expert Opinion on Pharmacotherapy 13, no
Bays, P
Pemvidutide Cuts NAFLD Liver Fat and Weight Through 24 Weeks
